Most Viewed Articles on HIV/AIDS
ART Works. But Researchers are Pursuing a Cure for HIV.
Results of a small study published in Nature Medicine show that early treatment with a monoclonal antibody might be part of a strategy to clear an HIV infection.
Positive Findings for Biktarvy Presented at HIV Research Meeting in Glasgow
Gilead Sciences reported results from several studies of its antiretroviral.
HIV Prevention, Treatment: Playing the Long Game
Drug manufacturers are developing long-acting, injectable HIV drugs for both treatment and prevention.
HIV Vaccine Trial Utilizing mRNA Underway
The decades-long quest for a vaccine against HIV has been fruitless so far. Moderna hopes an HIV vaccine that uses its messenger RNA technology will break the losing streak. A phase 1 trial designed to include 56 volunteers has started.
They Are Still There, Large and Looming: Barriers to HIV Testing and Care.
In a conversation with Managed Healthcare Executive®, Genoa Healthcare Sales Director Jennifer Finocchiaro discusses social determinants of health, the LGBTQ+ community and the demographic contours of the HIV/AIDS epidemic.
FDA Accepts NDA for Gilead's New HIV Prevention Shot
February 18th 2025Lenacapavir is a twice-yearly injectable medication designed to be used as pre-exposure prophylaxis (PrEP). The FDA is giving this drug a priority review and expects to make a decision by June 19, 2025, according to a release.
Read More
HIV + Hepatitis Institute Welcomes RFK, Talks Importance of Ending the HIV Epidemic
February 13th 2025The group released a statement today expressing that they are eager to work with Robert F. Kennedy Jr. to eradicate HIV when steps into his role as the Secretary of Health and Human Services.
Read More
